People suffering from depression in the UK have been promised easier access to counselling and 'talking therapies' by the government, …
Chantix, a new drug which could help smoker's kick their habit and boost Pfizer's sales by billions has been approved …
Kendle is to spend $215 million on buying the business of rivals Charles River, a move which the companys leaders …
Merck is to buy a pioneering biotech company, which discovers new monoclonal antibodies and then re-engineers them to make them …
Femara has been recommended for use in Scotland to prevent breast cancer returning after surgery, prompting its manufacturers and stakeholders …
A new slow-release drug for schizophrenia has been filed for approval in Europe by Jannsen-Cilag, the manufacturers of top-selling Risperdal.Paliperidone …
Sanofi-Aventis has recorded a major increase in its profits in the first three months of 2006, boosted by product growth …
AstraZeneca is to abandon its late-stage diabetes drug Galida after new results raised doubts about its safety.Galida is a PPAR …
The nation's increasing weight is to become top priority for frontline NHS staff in an effort to halt the rise …
Groundbreaking nanotechnology is behind a new drug, which AstraZeneca and co-marketers Abraxis BioScience believe could be a major advance in …
When the three 'Apprentices' enter Mr. Sugars boardroom to explain why they made such a hash of their latest project, …
It's getting personal. While the pharma industry continues to debate the end of the blockbuster model, hardly a single clinician, …
Better than expected results for a new drug for advanced breast cancer have led to trials being halted, in order …
The controversy surrounding Herceptin and its use in patients with early stage breast cancer has become a graphic illustration of …
While the prospect of a single-product company might seem attractive – no in-fighting over resource allocation, no conflicts of interest, …
Trained nurses and pharmacists in England now have the power to prescribe virtually any medicine, which could end the need …
Herceptin, the breast cancer drug at the centre of a long-running controversy could soon be available to thousands more women …
Introduced in April 2004, the new General Medical Services contract (nGMS) was hailed as a revolutionary new way of paying …
The needs of patients are being forgotten or over-looked by pharmaceutical companies, according to a newly launched consultancy called Patient …
Everyday, simple choices could be the key to a healthier lifestyle according to new government-backed research published by Cambridge University. …